Prescribing trends for anti-asthma drugs in tasmania following the National Asthma Campaign

被引:4
作者
Jacobson, GA [1 ]
Peterson, GM [1 ]
机构
[1] UNIV TASMANIA,FAC MED & PHARM,TASMANIAN SCH PHARM,HOBART,TAS 7001,AUSTRALIA
关键词
D O I
10.1111/j.1365-2710.1996.tb00025.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In recent years there has been a change in asthma pharmacotherapy, with considerably greater emphasis placed on the use of preventive therapy (inhaled corticosteroids and sodium cromoglycate) and less reliance on bronchodilator therapy. This study examined Tasmanian prescribing trends to determine whether the recommended changes in the treatment of asthma had transpired into practice and to compare the State prescribing trends with national Australian data. Computerized dispensing records, consisting of summarized monthly lists of all drugs dispensed, from almost one-third of all the community pharmacies within the State were retrospectively collected at intervals of 6 months between 1991 and 1994. Anti-asthma drugs were grouped into beta-agonists, inhaled corticosteroids, theophylline, ipratropium bromide and sodium cromoglycate, and quantities were converted to defined daily doses (DDDs)/1000 population/day, by extrapolation to the entire Tasmanian population. The Tasmanian data were compared with estimated national dispensing data for anti-asthma drugs provided by the Drug Utilization Subcommittee of the Pharmaceutical Benefits Advisory Committee. Tasmanian prescribing was generally similar to the national data, with large rises in the prescribing of inhaled corticosteroids (61% increase), ipratropium bromide (138% increase) and sodium cromoglycate (52% increase), and a decline in theophylline usage (43% decrease) over the period of the study. The prescribing of beta-agonists remained fairly stable over the period of the study, while there was a marked decrease in the ratio of dispensed DDDs of beta-agonists:inhaled corticosteroids (from 2.9 to 1.7). The overall usage of anti-asthma medication in Tasmania was found to be significantly higher than the national data for 1991 and 1992, with an April 1994 level of 74.7 DDDs/1000 population/day (an increase of 6% from April 1991). Tasmanian and national prescribing of anti-asthma drugs appears to have changed in line with current management guidelines, with greater emphasis on the use of inhaled corticosteroids. More attention could also be given to the prescribing of anti-allergy preventive drugs.
引用
收藏
页码:317 / 324
页数:8
相关论文
共 35 条
  • [21] EDUCATIONAL-PROGRAM TO IMPROVE THE DOSAGE PRESCRIBING OF ALLOPURINOL
    PETERSON, GM
    SUGDEN, JE
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 1995, 162 (02) : 74 - 77
  • [22] *PHARM GUILD AUSTR, 1994, 1994 GUILD DIG
  • [23] PHELAN PD, 1995, CURRENT THERAPEUTICS, V36, P57
  • [24] VARIATIONS IN THE TREATMENT OF CHILDHOOD ASTHMA
    PHIN, S
    OATES, RK
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 1993, 159 (10) : 662 - 666
  • [25] REGULAR INHALED BETA-AGONIST TREATMENT IN BRONCHIAL-ASTHMA
    SEARS, MR
    TAYLOR, DR
    PRINT, CG
    LAKE, DC
    LI, QQ
    FLANNERY, EM
    YATES, DM
    LUCAS, MK
    HERBISON, GP
    [J]. LANCET, 1990, 336 (8728) : 1391 - 1396
  • [26] THE USE OF BETA-AGONISTS AND THE RISK OF DEATH AND NEAR DEATH FROM ASTHMA
    SPITZER, WO
    SUISSA, S
    ERNST, P
    HORWITZ, RI
    HABBICK, B
    COCKCROFT, D
    BOIVIN, JF
    MCNUTT, M
    BUIST, AS
    REBUCK, AS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (08) : 501 - 506
  • [28] ASTHMA MANAGEMENT IN GENERAL-PRACTICE
    TSE, M
    BRIDGESWEBB, C
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 1993, 158 (11) : 766 - 770
  • [29] BRONCHODILATOR TREATMENT IN MODERATE ASTHMA OR CHRONIC-BRONCHITIS - CONTINUOUS OR ON DEMAND - A RANDOMIZED CONTROLLED-STUDY
    VANSCHAYCK, CP
    DOMPELING, E
    VANHERWAARDEN, CLA
    FOLGERING, H
    VERBEEK, ALM
    VANDERHOOGEN, HJM
    VANWEEL, C
    [J]. BRITISH MEDICAL JOURNAL, 1991, 303 (6815) : 1426 - 1431
  • [30] CHANGING PATTERNS OF ASTHMA MORTALITY - IDENTIFYING TARGET POPULATIONS AT HIGH-RISK
    WEISS, KB
    WAGENER, DK
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 264 (13): : 1683 - 1687